Suppression of PI3K/Akt/mTOR Signaling Pathway and Antioxidant System and Reversal of Cancer Cells Resistance to Cisplatin under the Effect of Curcumin

被引:0
|
作者
E. V. Kalinina
A. A. Sh. Hasan
V. V. Tatarskiy
Yu. L. Volodina
А. S. Petrova
M. D. Novichkova
D. D. Zhdanov
N. K. Nurmuradov
N. N. Chernov
A. A. Shtil
机构
[1] Peoples’ Friendship University of Russia (RUDN University),T. T. Berezov Department of Biochemistry
[2] Ministry of Health of the Russian Federation,Laboratory of Tumor Cell Death, N. N. Blokhin National Medical Research Center of Oncology
关键词
tumor cells drug resistance; gene expression; PI3K/AkT/mTOR signaling pathway; cisplatin;
D O I
暂无
中图分类号
学科分类号
摘要
The effect of curcumin on the resistance of SKOV-3 human ovarian adenocarcinoma cells to cisplatin was studied. It was found that curcumin induced “reversal” of cancer cells resistance, which was associated with suppression of the expression of genes encoding the key antioxidant enzymes (SOD1, SOD2, CAT, GPX1, and HO-1) and transcription factor Nrf2 and a decrease in the expression of genes encoding kinases of the PI3K/Akt/mTOR signaling pathway. The obtained results confirm the role of redox-dependent regulation in the “reversal” of cancer cells resistance to cisplatin.
引用
收藏
页码:371 / 375
页数:4
相关论文
共 50 条
  • [1] Suppression of PI3K/Akt/mTOR Signaling Pathway and Antioxidant System and Reversal of Cancer Cells Resistance to Cisplatin under the Effect of Curcumin
    Kalinina, E., V
    Hasan, A. A. Sh
    Tatarskiy, V. V.
    Volodina, Yu L.
    Petrova, A. S.
    Novichkova, M. D.
    Zhdanov, D. D.
    Nurmuradov, K.
    Chernov, N. N.
    Shtil, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 173 (03) : 371 - 375
  • [2] Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin
    A. A. Sh. Hasan
    E. V. Kalinina
    V. V. Tatarskiy
    Yu. L. Volodina
    А. S. Petrova
    M. D. Novichkova
    D. D. Zhdanov
    A. A. Shtil
    Bulletin of Experimental Biology and Medicine, 2022, 173 : 760 - 764
  • [3] Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin
    Hasan, A. A. Sh
    Kalinina, E., V
    Tatarskiy, V. V.
    Volodina, Yu L.
    Petrova, A. S.
    Novichkova, M. D.
    Zhdanov, D. D.
    Shtil, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 173 (06) : 760 - 764
  • [4] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [5] Effect of Curcumin on Gene Expression of Trx/TxrR System and PI3K/Akt/mTOR Signaling Pathway in SKOV3 Cells Resistant to Cisplatin
    Kalinina, Elena
    Hasan, Aseel Ali
    Petrova, Albina
    Novichkova, Maria
    Zhdanov, Dmitry
    Shtil, Alexander
    Chernov, Nikolai
    FREE RADICAL BIOLOGY AND MEDICINE, 2020, 159 : S55 - S55
  • [6] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [7] Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells
    Zhang, Y.
    Bao, C.
    Mu, Q.
    Chen, J.
    Wang, J.
    Mi, Y.
    Sayari, A. J.
    Chen, Y.
    Guo, M.
    NEOPLASMA, 2016, 63 (03) : 362 - 370
  • [8] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [9] Resistance to Cisplatin in NSCLC is Related to Autophagy Induced by PI3K/AKT/mTOR Signaling Pathway Inhibition
    Peng, Ling
    Miao, Ya-Fang
    Chen, Hao
    Wang, Qiu-Bo
    Wang, An
    Xue, Fei
    Zhou, Chao
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (03): : 482 - 489
  • [10] Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
    Shi, Ni
    Yu, Hao
    Chen, Tong
    ONCOTARGETS AND THERAPY, 2019, 12 : 7637 - 7647